Quick Takeaways
- James H. Stanker has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $61,609.
- Recent insider filing activity is available below.
Insider Trading & Ownership of James H. Stanker
- Location
- Frederick, MD
- Summary
- The estimated net worth of James H. Stanker is at least $61,609 dollars as of 02 Aug 2024. James H. Stanker is the Chief Financial Officer of Processa Pharmaceuticals, Inc. and owns shares of Processa Pharmaceuticals, Inc. (PCSA) stock worth about $61.6K.
- Signature
- /s/ James H. Stanker by Michael B. Kirwan, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow James H. Stanker and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Processa Pharmaceuticals, Inc. ($61,609).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of James H. Stanker
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | Chief Financial Officer | $61,609 | 05 Apr 2024 |
Insider Transactions Reported by James H. Stanker:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.